Lvdi Wang
Lvdi Wang
Microsoft Research Asia
Email verificata su microsoft.com
Titolo
Citata da
Citata da
Anno
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open …
C Zhou, YL Wu, G Chen, J Feng, XQ Liu, C Wang, S Zhang, J Wang, ...
The lancet oncology 12 (8), 735-742, 2011
38622011
Passive and active droplet generation with microfluidics: a review
P Zhu, L Wang
Lab on a Chip 17 (1), 34-75, 2017
4252017
Recent advances of cocktail chemotherapy by combination drug delivery systems
Q Hu, W Sun, C Wang, Z Gu
Advanced drug delivery reviews 98, 19-34, 2016
3412016
Review of heat conduction in nanofluids
J Fan, L Wang
Journal of heat transfer 133 (4), 2011
3302011
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell …
C Zhou, YL Wu, G Chen, J Feng, XQ Liu, C Wang, S Zhang, J Wang, ...
Annals of Oncology 26 (9), 1877-1883, 2015
2922015
Light‐Activated Hypoxia‐Responsive Nanocarriers for Enhanced Anticancer Therapy
C Qian, J Yu, Y Chen, Q Hu, X Xiao, W Sun, C Wang, P Feng, QD Shen, ...
Advanced materials 28 (17), 3313-3320, 2016
2902016
Rationally designed 1D Ag@ AgVO 3 nanowire/graphene/protonated gC 3 N 4 nanosheet heterojunctions for enhanced photocatalysis via electrostatic self-assembly and photochemical …
S Zhang, J Li, X Wang, Y Huang, M Zeng, J Xu
Journal of Materials Chemistry A 3 (18), 10119-10126, 2015
290*2015
Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression
TH Tseng, TW Kao, CY Chu, FP Chou, WL Lin, CJ Wang
Biochemical Pharmacology 60 (3), 307-315, 2000
2632000
Heat conduction: mathematical models and analytical solutions
L Wang, X Zhou, X Wei
Springer Science & Business Media, 2007
2492007
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
WZ Zhong, Q Wang, WM Mao, ST Xu, L Wu, Y Shen, YY Liu, C Chen, ...
The Lancet Oncology 19 (1), 139-148, 2018
2202018
Inhibitory effect of Hibiscus protocatechuic acid on tumor promotion in mouse skin
TH Tseng, JD Hsu, MH Lo, CY Chu, FP Chou, CL Huang, CJ Wang
Cancer Letters 126 (2), 199-207, 1998
2141998
Catalytic oxidation of vinyl chloride emission over LaMnO3 and LaB0. 2Mn0. 8O3 (B= Co, Ni, Fe) catalysts
C Zhang, C Wang, W Zhan, Y Guo, Y Guo, G Lu, A Baylet, ...
Applied Catalysis B: Environmental 129, 509-516, 2013
2002013
Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery
H Li, C Wang, J Yu, S Cao, F Wei, W Zhang, Y Han, X Ren
Cytotherapy 11 (8), 1076-1083, 2009
1922009
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN
B Liu, X Wu, B Liu, C Wang, Y Liu, Q Zhou, K Xu
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (11 …, 2012
1832012
Stability of dynamical systems
X Liao, LQ Wang, P Yu
Elsevier, 2007
1712007
Critical issues in nanofluids preparation, characterization and thermal conductivity
D Wu, H Zhu, L Wang, L Liu
Current Nanoscience 5 (1), 103-112, 2009
1592009
Nanofluids
S Choi, Y Jaluria, O Manca, L Wang
1502011
The electronic stethoscope
S Leng, R San Tan, KTC Chai, C Wang, D Ghista, L Zhong
Biomedical engineering online 14 (1), 1-37, 2015
1432015
Nanofluids research: key issues
L Wang, J Fan
Nanoscale Research Letters 5 (8), 1241-1252, 2010
1432010
Fabrication and characterization of monodisperse PLGA–alginate core–shell microspheres with monodisperse size and homogeneous shells for controlled drug release
J Wu, T Kong, KWK Yeung, HC Shum, KMC Cheung, L Wang, MKT To
Acta biomaterialia 9 (7), 7410-7419, 2013
1322013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20